EUVIMEDEUVIMED entdecken
Open Access

New Approaches to Treating Alzheimer's Disease

Hailin Zheng, Mati Fridkin, Moussa Youdim

Perspectives in Medicinal Chemistry · 2015

DOI: 10.4137/pmc.s13210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perspectives in Medicinal Chemistry, 2015. Verfasst von Hailin Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Intra-cellular Therapies Inc., New York, NY, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To date, no truly efficacious drugs for Alzheimer's disease (AD) have been developed; moreover, all new anti-AD drugs developed since 2003 have failed. To succeed where previous ones have failed in drug development, new approaches for AD therapy are needed. Here we discuss the potential application of network medicine as a new approach to AD treatment. Unlike traditional approaches focused on a single target/pathway, network medicine targets and restores disease-disrupted networks through simultaneous modulation of numerous proteins (targets)/pathways involved in AD pathogenesis. We consider several drug candidates under development for AD therapy, including Keap1–Nrf2 regulators, endogenous neurogenic agents, and hypoxia-inducible factor 1 (HIF-1) activators. These drug candidates are multi-target ligands with the potential to further develop as network medicines, since they act as master regulators to initiate a broad range of cellular defense mechanisms/cytoprotective genes that exert their efficacy in a holistic way. We also explore their diverse mechanisms of action and potential disease-modifying effects, which may have profound implications for drug discovery.

Schlagwörter

Stichwörter der Autor:innen

AChE-MAO-A/B inhibitorAlzheimer’s diseaseHIF-1 activatorKeap1–Nrf2 regulatorM30neurogenic agents

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Intra-cellular Therapies Inc., New York, NY, USA.
  • Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Abital Pharma Pipeline Ltd., Tel Aviv, Israel.

Zitieren

APA

Zheng, H., Fridkin, M., & Youdim, M. (2015). New Approaches to Treating Alzheimer's Disease. Perspectives in Medicinal Chemistry. https://doi.org/10.4137/pmc.s13210

Vancouver

Zheng H, Fridkin M, Youdim M. New Approaches to Treating Alzheimer's Disease. Perspectives in Medicinal Chemistry. 2015. doi:10.4137/pmc.s13210

BibTeX
@article{Zheng2015,
  author = {Zheng, Hailin and Fridkin, Mati and Youdim, Moussa},
  title = {New Approaches to Treating Alzheimer's Disease},
  journal = {Perspectives in Medicinal Chemistry},
  year = {2015},
  doi = {10.4137/pmc.s13210}
}
Kostenlos starten →